Jaume Pons - 19 Jul 2021 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
President & CEO, Director
Signature
/s/ Peter Garcia, by power of attorney
Issuer symbol
ALXO
Transactions as of
19 Jul 2021
Net transactions value
-$911,245
Form type
4
Filing time
20 Jul 2021, 16:12:58 UTC
Previous filing
22 Jun 2021
Next filing
03 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Sale $69,708 -1,300 -0.25% $53.62* 509,946 19 Jul 2021 Direct F1, F2
transaction ALXO Common Stock Sale $516,553 -9,500 -1.9% $54.37* 500,446 19 Jul 2021 Direct F1, F3
transaction ALXO Common Stock Sale $324,984 -5,900 -1.2% $55.08* 494,546 19 Jul 2021 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.95, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.03 to $55.23, inclusive.